EUVIMEDScopri EUVIMED
EditorialOpen access

A TCR-switchable cell death pathway in T-ALL

Christine Tran Quang, Benedetta Zaniboni, Jacques Ghysdael

Oncoscience · 2017-03-31 · 4 (3-4) · 17-18

DOI: 10.18632/oncoscience.342 ↗

At a glance

Editorial in Oncoscience, published on 2017-03-31. Written by Christine Tran Quang and 2 co-authors. Institution: Institut Curie, PSL Research University, CNRS UMR 3348, F-91405, Orsay, France; Université Paris Sud, Université Paris-Saclay, CNRS UMR 3348, F-91405…. Cited 4 times so far (Crossref). The full text is freely available in PubMed Central.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

In T-ALL an intrinsic, TCR-induced cell death pathway activates leukemic cell apoptosis.

Subjects

Author keywords

T-ALLTCR signalingcell deathnegative selectiontargeted therapy

Authors and institutions

  • Institut Curie, PSL Research University, CNRS UMR 3348, F-91405, Orsay, France; Université Paris Sud, Université Paris-Saclay, CNRS UMR 3348, F-91405 Orsay, France.

Cite

APA

Quang, C. T., Zaniboni, B., & Ghysdael, J. (2017). A TCR-switchable cell death pathway in T-ALL. Oncoscience, 4(3-4), 17-18. https://doi.org/10.18632/oncoscience.342

Vancouver

Quang CT, Zaniboni B, Ghysdael J. A TCR-switchable cell death pathway in T-ALL. Oncoscience. 2017;4(3-4):17-18. doi:10.18632/oncoscience.342

BibTeX
@article{Quang2017,
  author = {Quang, Christine Tran and Zaniboni, Benedetta and Ghysdael, Jacques},
  title = {A TCR-switchable cell death pathway in T-ALL},
  journal = {Oncoscience},
  year = {2017},
  volume = {4},
  number = {3-4},
  pages = {17--18},
  doi = {10.18632/oncoscience.342}
}
Start for free →